1-17 of 17
rice
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimal Use of Thai Sinlek Rice (IR) Provides the Nutraceutical Effect on Erythropoiesis in Rats

Pimpisid Koonyosying, PhD, Ben Flemming, BSc, Supachai Ekwattanakit, PhDMD, Vip Viprakasit, MD DPhil, Suthat Fucharoen, MD, Somdet Srichairatanakool, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4808.
https://doi.org/10.1182/blood-2019-129679
Published: 2019
Journal Articles

Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial

Andres JM Ferreri, MD, Jeanette K. Doorduijn, MD PhD, Chiara Cattaneo, MD, Maria Giuseppina Cabras, MD, Jeffery Smith, MBChB BMedSci MRCP FRCPath, Fiorella Ilariucci, Franco Narni, Teresa Calimeri, MD PhD, Alessandro Re, MD, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, MD, Luca Nassi, Kim Linton, MBChB PhD, Pam McKay, MD, Jacopo Olivieri, Caterina Patti, MD, Francesca Re, Alessandro Fanni, MD, Vikram Singh, MD, Jacoline Bromberg, MD, Kelly Cozens, Elisabetta Gastaldi, Nicola Cascavilla, Andrew Davies, MD PhD, Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, Maurizio Frezzato, MD, Wendy Osborne, MBBS, Anna Marina Liberati, Urban Novak, Renato Zambello, Emanuele Zucca, MD, Kate Cwynarski, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 353.
https://doi.org/10.1182/blood-2019-129835
Published: 2019
Journal Articles

A Phase 1a/b Dose Escalation Study of Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS

Stephen B Howell, MD, Hongying Zhang, MD PhD, William G Rice, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5148.
https://doi.org/10.1182/blood-2019-129685
Published: 2019
Journal Articles

Synthetic Lethal Interaction between Apto-253 and IDH1/2 Mutations

Cheng-Yu Tsai, PhD, Hongying Zhang, MD PhD, William G Rice, PhD, Stephen B Howell, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5755.
https://doi.org/10.1182/blood-2019-123571
Published: 2019
Journal Articles

Non-Effectiveness of Using RICE Post RDHAP or RDHAP Post RICE after Failure of First Line Salvage Therapy in DLBCL Patients Who Are Eligible for ASCT

Tony Ibrahim, MD MSc, Tarek Assi, Julien Lazarovici, MD, Maxime Annereau, PharmD, David Ghez, MD PhD, Jean-Marie Michot, MD, Julia Arfi-Rouche, Julien Rossignol, MD PhD, Veronique Vergé, Jacques Bosq, Peggy Dartigues-Cuillères, MD, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4226.
https://doi.org/10.1182/blood-2018-99-117444
Published: 2018
Journal Articles

A Phase 1/2 Study of Carfilzomib Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide (C-RICE) in Patients with Transplant-Eligible, Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Pallawi Torka, MD, Seema Bhat, Kelvin P. Lee, MD, Alan Hutson, Jenna Nichols, Angela Kader, Cory Mavis, MSc, AnneMarie W Block, Sheila N. J. Sait, PhD, Bora E Baysal, MD PhD, Fadi Habib, MD, Vishala T. Neppalli, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2822.
https://doi.org/10.1182/blood.V130.Suppl_1.2822.2822
Published: 2017
Journal Articles

An Integer Weighted Genomic Mutation Scoring (IWGMS) Using the Trusight Myeloid Sequencing Panel (Illumina) Shows Higher Mortality in Patients with Intermediate Risk Acute Myeloid Leukemia- a Retrospective Study

Xinyu Nan, MD, Michael Greenwood, MD, Cesar Gentille Sanchez, MD, Yan Xing, MD PhD, Arthur Zieske, MD, Ibrahim Ibrahim, MD, Kelty Baker, MD, Lawrence Rice, MD, Brian Merritt, Sai Ravi Pingali, MD, Randall J Olsen, MD, Swaminathan P. Iyer, MD
Journal: Blood
Blood (2016) 128 (22): 2889.
https://doi.org/10.1182/blood.V128.22.2889.2889
Published: 2016
Journal Articles

A Phase 1 Study of Denintuzumab Mafodotin (SGN-CD19A) in Relapsed/Refactory B-Lineage Non-Hodgkin Lymphoma

Craig H Moskowitz, Michelle A Fanale, Bijal D Shah, Ranjana H Advani, MD, Robert Chen, Stella Kim, Ana Kostic, Tina Liu, Joanna Peng, Andres Forero-Torres
Journal: Blood
Blood (2015) 126 (23): 182.
https://doi.org/10.1182/blood.V126.23.182.182
Published: 2015
Journal Articles

Clonal Events in Normal Aging Hematopoiesis

Lambert Busque, MD
Journal: Blood
Blood (2015) 126 (23): SCI-10.
https://doi.org/10.1182/blood.V126.23.SCI-10.SCI-10
Published: 2015
Journal Articles

Case Series of Primary Breast Diffuse Large B-Cll Lymphoma in Ampang Hospital, Malaysia

Jew Win Kuan, MRCP, Ngee-Siang Lau, Lily L Wong, Lee-gong Lau, MBBS, MRCP, Kian Meng Chang, FRCPA
Journal: Blood
Blood (2012) 120 (21): 5113.
https://doi.org/10.1182/blood.V120.21.5113.5113
Published: 2012
Journal Articles

Therapy-Related Pro-B Cell Acute Lymphoblastic Leukemia: Report of Two Patients with MLL Amplification

Frederick Racke, MD, PhD, Carol Cole, Nyla A. Heerema, PhD
Journal: Blood
Blood (2011) 118 (21): 4911.
https://doi.org/10.1182/blood.V118.21.4911.4911
Published: 2011
Journal Articles

MYC + Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report

Wendy Cuccuini, Josette Briere, Nicolas Mounier, MD, PhD, Hans-Ullrich Voelker, Andreas Rosenwald, MD, Christer Sundstrom, MD, PhD, Sergio Cogliatti, Dominique Bron, MD, Edouard Hirchaud, Jean Soulier, MD, Philippe Gaulard, MD, Remi Houlgatte, C. Gisselbrecht, MD, Catherine Thieblemont, MD
Journal: Blood
Blood (2011) 118 (21): 594.
https://doi.org/10.1182/blood.V118.21.594.594
Published: 2011
Journal Articles

Efficacy of RICE as Second Line Chemotherapy in Transplant Ineligible Patients with Diffuse Large B Cell Lymphoma: a Single Institution Experience.

Mousami Shah, Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm, D, Bety Ciobanu, MD, Rosalind Catchatourian, MD
Journal: Blood
Blood (2009) 114 (22): 4757.
https://doi.org/10.1182/blood.V114.22.4757.4757
Published: 2009
Journal Articles

Rituximab Maintenance Following High Dose Therapy and Autologous Stem Cell Rescue after RICE Cytoreduction Improves Event Free and Overall Survival

Robert D. Rice, MSN, PhD(c), Craig H. Moskowitz, MD, Tarun Kewalramani, MD, Daniel O. Persky, MD, Brian T. Rafferty, Jocelyn C. Maragulia, Andrew D. Zelenetz, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1280.
https://doi.org/10.1182/blood.V110.11.1280.1280
Published: 2007
Journal Articles

RICE/ICE Is an Effective PBSC Mobilising Regime in Patients with Aggressive Lymphoma.

Edward Wilson, Rachel Pawson, Kathleen Beston, John Smyth, Chris Hatton
Journal: Blood
Blood (2005) 106 (11): 5513.
https://doi.org/10.1182/blood.V106.11.5513.5513
Published: 2005
Journal Articles

A Prospective Phase II Comparison of Stem Cell Source Using Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) RE—Induction, Then High Dose Fludarabine, Busulfan (FLUBU) and Autologous (ASCT) or Allogeneic (AlloSCT) Hematopoietic Blood Stem Cell Transplantation for Mantle Cell (MCL) and Relapsed Low-Grade B-Cell Non-Hodgkin’s Lymphoma (NHL).

Douglas A. Stewart, MD, FRCPC, Michael Voralia, MD, FRCPC, Ahsan Chaudhry, MD, Oluyemi Jeje, MD, Donald Morris, MD, FRCPC, Lynn Savoie, MD, FRCPC, Chris Brown, MD, FRCPC, Wanda Hasagawa, MD, FRCPC, Nizar Bahlis, MD, James R. Russell, MB, BChir, FRCPC
Journal: Blood
Blood (2004) 104 (11): 915.
https://doi.org/10.1182/blood.V104.11.915.915
Published: 2004
Journal Articles

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Tarun Kewalramani, Andrew D. Zelenetz, Stephen D. Nimer, Carol Portlock, David Straus, Ariela Noy, Owen O'Connor, Daniel A. Filippa, Julie Teruya-Feldstein, Alison Gencarelli, Jing Qin, Alyson Waxman, Joachim Yahalom, Craig H. Moskowitz
Journal: Blood
Blood (2004) 103 (10): 3684–3688.
https://doi.org/10.1182/blood-2003-11-3911
Published: 2004